AbbVie Balance Sheet Health
Financial Health criteria checks 3/6
AbbVie has a total shareholder equity of $10.4B and total debt of $60.6B, which brings its debt-to-equity ratio to 582.7%. Its total assets and total liabilities are $134.7B and $124.3B respectively. AbbVie's EBIT is $17.4B making its interest coverage ratio 10.5. It has cash and short-term investments of $12.8B.
Key information
582.7%
Debt to equity ratio
US$60.58b
Debt
| Interest coverage ratio | 10.5x |
| Cash | US$12.82b |
| Equity | US$10.40b |
| Total liabilities | US$124.31b |
| Total assets | US$134.71b |
Recent financial health updates
No updates
Recent updates
AbbVie's Q1: Positive Surprise
Apr 26AbbVie: Great To Be Proven Wrong - Still Not A Buy
Apr 14AbbVie: Still Fits Buffett's 10x EBT Rule Well Despite Guidance Revision
Apr 08AbbVie: Strong Cash Flow Growth Fuels Dividend Growth
Mar 08AbbVie: Things Are Getting Clearer
Feb 05AbbVie Q4 Earnings Preview: Few Clouds On Horizon Thanks To Masterful Management (Rating Upgrade)
Jan 30AbbVie (NYSE:ABBV) Is Increasing Its Dividend To $1.55
Jan 05
AbbVie: Time To Lock In Gains (Rating Downgrade)
Jan 03AbbVie Vs. GSK: Dual Dominance In Pharma
Dec 23AbbVie's (NYSE:ABBV) Upcoming Dividend Will Be Larger Than Last Year's
Dec 124.5%-Yielding AbbVie Is One Of My Favorite Value Plays For 2024
Nov 29AbbVie (NYSE:ABBV) Has Announced That It Will Be Increasing Its Dividend To $1.55
Nov 28AbbVie Vs. Amgen: How Peter Lynch Picks Dividend Stocks
Nov 21AbbVie (NYSE:ABBV) Will Pay A Larger Dividend Than Last Year At $1.55
Oct 30AbbVie Stock Still A Hold Despite Positive Third Quarter 2023 Results
Oct 30AbbVie Q3 Earnings Preview: Tough Comparison For Humira Shouldn't Derail Growth Plans
Oct 23AbbVie: Successfully Navigating Humira's Patent Cliff With 4% Yield And 270% DGR Since 2014
Oct 16Financial Position Analysis
Short Term Liabilities: ABBV's short term assets ($33.0B) do not cover its short term liabilities ($37.8B).
Long Term Liabilities: ABBV's short term assets ($33.0B) do not cover its long term liabilities ($86.5B).
Debt to Equity History and Analysis
Debt Level: ABBV's net debt to equity ratio (459.4%) is considered high.
Reducing Debt: ABBV had negative shareholder equity 5 years ago, but is now positive and has therefore improved.
Debt Coverage: ABBV's debt is well covered by operating cash flow (37.7%).
Interest Coverage: ABBV's interest payments on its debt are well covered by EBIT (10.5x coverage).